European Federation for Cancer Images -EUCAIM-

EUCAIM

Duration

4 years

Website

https://cancerimage.eu/

Partners

76 partners

Budget

€35,5 million

The process

Description

EUropean Federation for CAncer IMages (EUCAIM) is the cornerstone of the European Commission-initiated European Cancer Imaging Initiative, a flagship of Europe’s Beating Cancer Plan (EBCP), which aims to foster innovation of digital technologies in cancer treatment and care to achieve more precise and faster clinical decision making, diagnostics, treatment and predictive medicine for cancer patients.

This infrastructure will support the development and validation of AI tools toward Precision Medicine. Such AI tools will support and enhance the (cancer) diagnosis procedure, treatment and the identification of the need for predictive medicine. Overall, this infrastructure will provide a platform for developing AI tools that aim to enhance cancer treatment and the diagnosis procedure for patients.

MATICAL’s role

Part of the proposal preparation team.
Member of the Project’s Coordination Committee. Leader of the Sustainability strategy.

Programme / Type

Digital Europe

Area

Healthcare, Cancer diagnosis and treatment, Computing technologies, AI, Machine Learning, Big Data, European Health Data Space (EHDS)

Ready to elevate your innovation journey?

Matical Innovation

+34 624 048 221

Let us guide you

The process

Description

MATICAL’s role

Part of the proposal preparation team.
Member of the Project’s Coordination Committee. Leader of the Sustainability strategy.

Programme / Type

Digital Europe

Area

Healthcare, Cancer diagnosis and treatment, Computing technologies, AI, Machine Learning, Big Data, European Health Data Space (EHDS)

Let's innovate with purpose!

In embracing these core principles, we ensure our contributions to the health sector are meaningful, impactful, and consistent with our mission. We invite you to partner with us, to create a healthier, brighter future together.

Partners & Collaborative Networks

We are the strategic partners of choice for leading EU biotech enterprises and technology transfer offices. With us, they assess their innovations’ impact, formulate robust go-to-market strategies, and analyze cost-benefits for novel medical devices and associated technologies. Our expansive network encompasses the most influential figures in the EU health sector, from cutting-edge biotech firms, where health data is paramount, to AI-driven solutions targeting cancer and rare diseases.